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On a hot day in almost any city in the world, if you ask
someone what the temperature is, you might not be surprised
to hear them answer ‘35’. We all know what this means—the
temperature is 351C and the report is a product of the
environment and the instrument we use to measure its
properties. If, however, you were to ask the same question
on an equally hot day in a city in the United States, where we
stridently avoid SI units in our every day lives, the answer you
would receive is ‘95’ (degrees Fahrenheit for those of you who
are not familiar with our antiquated system of measurement).
Same levelof heat, same averagemolecular kinetic energy, but
a different answer to the same question. Does that mean we
should abandon measurement of temperature? No. What it
means is that we have to understand how the measurements
are made and how to relate them to each other. The
thermometers being used are not at fault, they are just
measuring the same thing in slightly different ways. It is the
type of problem we as scientists deal with all the time.
Which is why I am so perplexed by the way in which DNA
microarrays have been singled out as being of questionable
value in expression analysis. First, we have to recognize that
notechnologywehaveavailablemeasuresgeneexpression.At
best, what microarrays, or Northern blots, or SAGE, or QRT-
PCR measure is RNA abundance. But even that is not quite
true.Wearenotgivenanaccountingofindividualmoleculesin
a sample (and no, SAGE doesn’t do this either, even though the
output is a numeric count of observed tags). What each
technology gives us is a surrogate measure of RNA abun-
dance—a ﬂuorescence intensity, a band intensity, a tag count,
or a Ct value. And each of these has its own biases, limitations,
and weaknesses.
Second, among the publications in which various applica-
tions of DNA technology have been compared and found to be
lacking, the authors generally either ﬁnd that the expression
measures between two conditions depend on the particular
microarray platform being used or that measurements made
on the same ‘biological system’ (tumor versus normal, for
example) in two different studies produce lists of signiﬁcant
genes that are not highly concordant. In the former case, much
like in measuring temperature, we have to understand whether
we are measuring the same thing in the same way (or the same
thousands of things in the same thousands of ways). For the
latter, even in studies that use the same instruments, it is not
clear that the samples under study, even if they carry the same
labels,aretrulythesameandtheproblemofcomparinglistscan
be effectively handled if well annotated high-quality data with
information regarding the samples are available in public
repositoriessothatwe can constantlyimprove ourconclusions.
The question of measurement and bias in DNA microarrays
was recently addressed by Kuo et al (2006) in the most
comprehensive analysis to date. Using 10 different microarray
platforms and two QRT-PCR methods for comparison, Kuo
et al’s analysis reveals some interesting facts. First, each of the
platforms alone is highly consistent and reproducible. This
observation is of crucial importance because it demonstrated
that the basic technology is, for each probe on the array,
making measurements that can be replicated. The same is true
when comparing array results with QRT-PCRanalyses or when
comparing different QRT-PCR technologies.
Second, although the correlation between platforms is fairly
good, it improves signiﬁcantly if one limits the analysis to
probes that overlap with each other. This goes beyond simply
assigning probes to the same gene. Using correlation across
platform as a measure, probes from the same RefSeq exon
outperform those mapping to the same RefSeq gene, which are
in turn better than those mapping to the same Locus Link
accessions, and ﬁnally, these outperform those mapping to the
sameUniGenecluster.Therearemanypotentialreasonsforthis,
ranging from alternate splicing to different sequence speciﬁcity,
but the bottom line is that probes are more likely to correlate
in their measurements if they are measuring the same thing.
One should note that manufacturers of the arrays are not at
fault here. The problem here is that we are still working in
partial darkness. Despite the fact that the human genome
sequence has once again been declared ‘ﬁnished’ (Gregory
et al, 2006), we still do not have a comprehensive catalog of all
ofthegenes,thetranscriptstheyencode,theirvariants,ortheir
genomic structures (and we can still debate exactly what
a gene is or how many exist in the human or other genomes).
In many ways, arrays themselves have the best potential to
solve this problem, as tiling arrays are, at present, the best
experimental tool for elucidating transcripts and their variants
on a global scale. And as the genome sequence and its
annotation evolve, so will array technologies.
Third, the quality of commercial arrays has improved so
that, in this study, the commercial arrays outperformed those
made ‘in house.’ This again is not surprising as manufacturers
whose goal is producing a product are generally better
positioned to assure high quality than researchers whose
primary interest is in the use of those products. Indeed,
commercial organizations should be commended for increas-
ing quality while decreasing price so that more laboratories
have the opportunity to apply DNA microarray expression
analysis in their experimental programs.
Finally, the correlation between platforms is best for genes
expressed at moderate to high levels. Again this is not
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Article number: 63surprising but it is important. Many of the genes in which we
may be most interested, including many transcription factors,
are expressed at relatively low levels. However, when the
signal is close to the background noise, making precise
measurements is difﬁcult and this is true of any technology.
So are microarrays reliable? The weight of the evidence
presented by Kuo and his colleagues demonstrates that if the
experiments are performed carefully and if the data are
analyzed in a consistent manner, then the signal from the
biology dominates the choice of technology—particularly if
each technology platform is measuring the same thing. This is
because, fundamentally, every measurement is a convolution
of the quantity being measured and the instrument being used
to measure it. If we fully understand this principle, then
appropriate experimental design and optimal use of the data
will enable us to exploit better our measurements for
discovery.
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